Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
13,017
datasets available to search
ShareScore release 0.9.0
Dataset results
13,017 results for “Positionning”
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
ClinicalTrials.gov study NCT04124536. IPD Sharing: YES. Countries: 1. Publications: 1.
FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression
ClinicalTrials.gov study NCT02325739. IPD Sharing: YES. Countries: 11. Publications: 2.
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
ClinicalTrials.gov study NCT01160211. IPD Sharing: YES. Countries: 29. Publications: 2.
Study of Nilotinib as First Line Treatment in Philadelphia Chromosome Positive(Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
ClinicalTrials.gov study NCT01274351. IPD Sharing: YES. Countries: 1. Publications: 2.
Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD
ClinicalTrials.gov study NCT03901534. IPD Sharing: YES. Countries: 1. Publications: 3.
DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]
ClinicalTrials.gov study NCT03529110. IPD Sharing: YES. Countries: 15. Publications: 9.
A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours
ClinicalTrials.gov study NCT01578239. IPD Sharing: YES. Countries: 8. Publications: 4.
Positive Psychology Intervention In HSCT
ClinicalTrials.gov study NCT05147311. IPD Sharing: YES. Countries: 1. Publications: 1.
Phase 2 Study of Brigatinib in Japanese Participants With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03410108. IPD Sharing: YES. Countries: 1. Publications: 2.
Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD).
ClinicalTrials.gov study NCT01682083. IPD Sharing: YES. Countries: 25. Publications: 9.
A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate, Midazolam, in Participants With ALK-Positive or ROS1-Positive Solid Tumors
ClinicalTrials.gov study NCT03420742. IPD Sharing: YES. Countries: 4. Publications: 1.
Tailoring Maintenance Therapy to Cluster of Differentiation 5 Positive (CD5+) Regulatory B Cell Recovery in ANCA Vasculitis
ClinicalTrials.gov study NCT03906227. IPD Sharing: YES. Countries: 1. Publications: 1.
Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.
ClinicalTrials.gov study NCT01844765. IPD Sharing: YES. Countries: 13. Publications: 3.
Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma
ClinicalTrials.gov study NCT02083354. IPD Sharing: UNDECIDED. Countries: 5. Publications: 2.
Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer
ClinicalTrials.gov study NCT00263588. IPD Sharing: UNDECIDED. Countries: 17. Publications: 1.
NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer
ClinicalTrials.gov study NCT01816594. IPD Sharing: YES. Countries: 4. Publications: 1.
A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)
ClinicalTrials.gov study NCT01578499. IPD Sharing: YES. Countries: 12. Publications: 5.
DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart Transplant
ClinicalTrials.gov study NCT03208244. IPD Sharing: YES. Countries: 1. Publications: 1.
Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00820222. IPD Sharing: UNDECIDED. Countries: 14. Publications: 1.
LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib
ClinicalTrials.gov study NCT01828112. IPD Sharing: UNDECIDED. Countries: 20. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.